Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data...

Por Orucevic, Amila, Heidel, Robert E., Bell, John L.
Publicado no Breast Cancer Res Treat (2016)

Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data

Por Orucevic, Amila, Bell, John L., McNabb, Alison P., Heidel, Robert E.
Publicado no Breast Cancer Res Treat (2017)

Comparing Team-Based and Mixed Active-Learning Methods in an Ambulatory Care Elective Course

Por Zingone, Michelle M., Franks, Andrea S., Guirguis, Alexander B., George, Christa M., Howard-Thompson, Amanda, Heidel, Robert E.
Publicado em 2010

Breast Cancer in Elderly Caucasian Women—An Institution-Based Study of Correlation between Breast Cancer Prognostic Markers, TNM Stage, and Overall Survival

Por Orucevic, Amila, Curzon, Matthew, Curzon, Christina, Heidel, Robert E., McLoughlin, James M., Panella, Timothy, Bell, John
Publicado no Cancers (Basel) (2015)